REVUMENIB vs RIBOFLAVIN 5'-PHOSPHATE: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
REVUMENIB vs RIBOFLAVIN 5'-PHOSPHATE: Safety Overview
| Metric | REVUMENIB | RIBOFLAVIN 5'-PHOSPHATE |
|---|---|---|
| Total FAERS Reports | 371 | 249 |
| Deaths Reported | 49 | 0 |
| Death Rate | 13.2% | N/A |
| Hospitalizations | 93 | 3 |
| Average Patient Age | 46.4 yrs | 31.1 yrs |
| % Female Patients | 47.6% | 31.4% |
| FDA Approval Date | Nov 15, 2024 | Apr 15, 2016 |
| Manufacturer | Syndax Pharmaceuticals, Inc. | N/A |
| Route | ORAL | N/A |
| Marketing Status | Prescription | Prescription |